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Objectives: There remains no consensus on what constitutes an adequ te margin of resection for 
non-infiltrative soft-tissue sarcomas (STSs). We aimed to investigate the role of resection margins in 
millimetres for non-infiltrative STSs. 
Methods: 502 patients who underwent surgical resection for a l c lized, non-infiltrative, high-grade 
STSs were studied. The prognostic significance of margin width was analysed and compared with 
the conventional R- and R+1-classification of surgical margins. 
Results: The overall local recurrence (LR) rate was 13%; 9% and 27% with negative and positive 
margins, respectively (p<0.001). In patients with negative margins, the LR rates were greater than 
10% in patients with margins ≤ 5.0 mm but reduced to less than 4% with margins > 5.0 mm. When 
classified by the R- (or R+1)-classification, the 5-year cumulative LR incidence was 8%, 23% (16%), 
and 31% for R0, R1, and R2, respectively, which did not stratify the LR risk with negative margins. 
On the other hand, an accurate risk stratification was possible by metric distance; the 5-year 
cumulative incidence of LR was 29%, 10%, and 1% with 0mm, 0.1–5.0mm, and >5.0mm, 
respectively (p<0.001). This classification also stratified the LR risk in patients with or without 
adjuvant radiotherapy.  
Conclusion: While a negative margin is essential to optimize loca  control in patients with 
non-infiltrative STSs, surgical margin width greater han 5mm minimises the risk of local failure 




The role of surgical margin achieved at resection is critical for the management of bone and 
soft-tissue tumours [1-5]. However, there is no consensus on how surgical margins are evaluated 
among different institutes worldwide. The most frequ ntly reported system has been the 
Musculoskeletal Tumour Society (MSTS) system which records margin status as intralesional, 
marginal, wide and radical [6]. Whilst there remains no doubt what constitutes an intralesional or 
radical margin, the interpretation of a wide or marginal margin is subjective and varies depending 
between investigators and centres [7]. The effect of the closest margin measured in millimetres has 
been reported for osteosarcoma [7], chondrosarcoma [8], nd soft-tissue sarcomas (STSs) [1, 3, 4, 
9-16]. This method provides prognostic risk stratification by offering a clear, objective, and 
reproducible way of interpreting resection margins. For STSs, however, the majority of evidence 
reports heterogeneous groups of histological subtypes. Since infiltrative STSs, such as 
myxofibrosarcoma and undifferentiated pleomorphic sarcomas, generally necessitate more extensive 
surgical margin when compared to non-infiltrative subtypes [15, 17, 18], a more detailed assessment 
of what constitutes an adequate margin for the non-i filtrative subtypes is required. 
It is universally accepted from the available literature that a microscopically negative 
margin following resection is associated with a lower risk of local recurrence [11, 19-23]. These 
studies were performed using the Enneking system [6], R-classification [24], or R+1-classification 
by the Union for International Cancer Control (UICC) [25]. In the R-classification, R2 resection 
describes intralesional resection; R1 resection is defined as a resection with microscopically 
contaminated margins or marginal resection along a pseudo-capsule; R0 resection is defined as a 
resection with macroscopically and microscopically negative margins [24]. In the R+1 classification, 
R2 involves macroscopic tumour contamination, R1 describes a margin with < 1 mm; R0 is defined 
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as a margin with ≥ 1mm [25]. Whilst the R or R+1 classification offers a metric 1 mm cut-off [26], 
fewer publications have discussed the effect of margins over 1 mm. Furthermore, the prognostic 
significance of margin width remains undefined, which could be attributed to the heterogeneity in 
histological diagnoses, and the small numbers reviewed. Thus, there remains no consensus on what 
how wide of a margin is necessary in opitimising local disease control for STSs. 
The aim of this study, therefore, was to investigate the role of resection margins in 
millimetres for non-infiltrative STSs and to determine what constitutes an adequate margin for 
optimising local control. 
 
Patients and methods 
Patients were identified from a prospectively mainti ed database at a single tertiary referral sarcoma 
centre. All patients treated with a diagnosis of STS surgically treated between 1996 and 2016 were 
eligible. The study population comprised 2,984 patients, of which 2,177 underwent surgical 
treatment at our institute. Inclusion criteria included primary, localised, intermediate- or high-grade 
STSs. Exclusion criteria included patients with secondary sarcoma, locally recurrent or metastatic 
disease at presentation, low-grade STS such as well-diff rentiated liposarcoma and 
dermatofibrosarcoma protuberans, and infiltrative histological subtypes including myxofibrosarcoma 
and undifferentiated pleomorphic sarcoma. Having applied these criteria, 902 eligible patients were 
identified of whom 502 had complete histological data included resection margin, in millimetres.  
 Treatments for all patients were managed by a formally constituted sarcoma multiple 
disciplinary team, in which decisions about surgery, chemotherapy, radiotherapy and the timing of all 
these modalities was made. Chemotherapy was considered for borderline resectable tumours, which 
was also guided by the histological diagnosis. Radiotherapy was considered preoperatively for 
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myxoid liposarcoma in a recent decade and postoperativ ly for those with large, deep tumours with 
close or intralesional margin. 
Clinical data collected included age at diagnosis, ex, histopathological diagnosis, tumour 
site, size, depth, grade, stage, surgical margin, adjuv nt therapy, and oncological outcome. Tumour 
stage was classified according to the UICC classificat on (8th edition) [27]. The closest resection 
margin was evaluated by an experienced pathologist after gross examination of the formalin-fixed 
specimens. The resection margin was recorded in millimetres, and also classified according to two 
conventional classifications; the R-classification a d R+1 mm classification. This study was 
approved by the institutional review board and all d ta was collected from the clinical records and 
imaging systems as part of routine patient follow-up. 
The primary endpoints in this study were LR and disease-specific mortalities. The 
cumulative incidence of LR and disease-specific mortality were estimated using a competing risk 
analysis. Death or metachronous distant metastases, whichever occurred first, was regarded as a 
competing event to LR. Deaths by nononcological causes were regarded as competing risks to 
disease-specific mortality. Multivariate analysis was performed using the Fine–Gray model and 
subdistribution hazard ratios were calculated for the final predictor variables. Statistical analyses 
were performed using R software version 3.5.5. Differences were considered statistically significant 




A total of 502 patients with primary, localised STS were available for analysis after exclusion criteria. 
Baseline patient characteristics are summarised in Table 1. The median age at diagnosis was 52 
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years (range, 2 to 92 years), 300 males (60%) and 202 females (40%). Of these, 339 (68%) presented 
with lower extremity and 91 (18%) with upper extremity tumours. Most tumours were high-grade 
(FNCLCC grade 3, 61%; grade 2, 39%). The majority of tumours were located deep to the fascia 
(72%). The most frequent histopathological diagnosis was synovial sarcoma (n=122; 24%), followed 
by myxoid liposarcoma (n=119; 24%), leiomyosarcoma (n=88; 18%), and malignant peripheral 
nerve sheath tumor (MPNST) (n=66; 13%) (Table 1). The median tumour size, the greatest diameter 
measured in the excised specimen, was 9 cm (range, 0.4 to 42 cm). The tumour stage of disease at 
presentation was IIA in 124 patients (25%), IIB in 75 (15%), and III in 300 (60%), classified 
according to the AJCC criteria [28]. Chemotherapy was performed in 79 patients (16%); 
preoperatively in 33 patients, postoperatively in 38 patients, and both before and after operative 
treatment in 5 patients. The use of radiotherapy was common (75%), which was administered 
preoperatively in 40 patients, postoperatively in 330 patients, and both before and after operative 
treatment in 3 patients. 
 
The relationship between resection margin in millimetres and local control 
Details of resection margin obtained are summarised in Table 2. When classified by the 
R-classification, a total of 52 patients (10%), 42 (8%), and 408 (81%) were resected with 
macroscopically positive (R2), microscopically positive (R1), and microscopically negative margin 
(R0). When classified by the R+1 system, the number of microscopically negative margin (R0) 
decreased to 360 patients (72%), with an increase in the number of patients with microscopically 
positive margins (n=90; 18%). 
 The overall LR rate for all patients was 13% (n=64). The relationship between margin in 
millimetres and local recurrence is shown in Table 2. The LR rates were 27% and 9% in patients 
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with positive and negative margin, respectively (p<0.001). In patients with a negative margin, the LR 
rates were greater than 10% with margins ≤ 5.0 mm but the rates decreased to less than 4% with 
margins > 5.0 mm. Patients were therefore categorised according to the margin achieved, measured 
in millimetres, into three groups for further analysis; group 1, 0 mm; group 2, 0.1–5.0 mm; group 3, 
> 5.0 mm. 
 The cumulative incidence of LR was 8% (95% CI, 6–11%), 12% (95% CI, 9–15%), and 
16% (95% CI, 12–20%) at 2, 5, and 10 years, respectively. The cumulative incidence of LR at 5 
years according to the R-classification was 8% (95% CI, 6–11%) for R0 margins, 23% (95% CI, 10–
39%) for R1 margins, and 31% (95%CI, 19–44%) for R2 margins (p<0.001; Figure 1A). The 5-year 
cumulative incidence of LR when classified according to the R+1-classification was 8% (95% CI, 8–
12%) for R0 margins, 16% (95% CI, 8–27%) for R1 margins, and 31% (95%CI, 19–44%) for R2 
margins (p<0.001; Figure 1B). No significant differences in the cumulative LR incidence were 
observed with regard to R0 or R1 resection using R+1-classification in patients with negative margin 
(p=0.425; Supplementary Figure 1A). On the other hand, when margins were classified according 
to the three-group classification, the cumulative incidence of LR at 5 years was 29% (95% CI, 19–
39%) for group 1, 10% (95% CI, 7–14%) for group 2, and 1% (95% CI, 0.1–6%) for group 3 
(p<0.001; Figure 1C). This classification stratified the risk of LR with statistical significance in 
patients with negative margin (p=0.003; Supplementary Figure 1B). 
When including the use of adjuvant radiotherapy with the novel classification system, the 
5-year cumulative LR incidence was 29% (95% CI, 19–40%) for group 1, 9% (95% CI, 6–13%) for 
group 2, and 0% for group 3 (p<0.001; Figure 2A). In patients who underwent surgical resection 
alone, the cumulative LR incidences at 5 years were 28% (95% CI, 5–57%), 14% (95% CI, 5–26%), 
and 2% (95% CI, 0.1–8%) for group 1, group 2, and group 3, respectively (p=0.004; Figure 2B). 
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In the univariate analysis, a significant association between tumour size, R-classification, 
R+1-classification, and the novel margin classification system was seen with respects to LR. There 
was no significant association between the cumulative incidence of LR and gender, tumour site, 
grade, unplanned excision (‘whoops’ surgery), and the use of adjuvant therapy. The multivariate 
analysis was performed using Fine–Gray subdistribution hazard model based on the R-classification, 
R+1-classification, and the novel margin classification system. The R-classification demonstrated 
that R2 and R1 resections had 4.8× (HR, 4.818; 95% CI, 2.655–8.742; p<0.001) and 2.9× (HR, 
2.907; 95% CI, 1.227–6.886; p=0.015) LR risk compared to R0 resection. According to the 
R+1-classification, R2 and R1 resections had 5.2× (HR, 5.237; 95% CI, 2.813–9.750; p<0.001) and 
2.3× (HR, 2.301; 95% CI, 1.118–4.737; p=0.024) LR risk, compared to R0 resection. When 
analysing the novel classification system, a positive margin or a margin of ≤ 5 mm, compared to > 5 
mm, had 68.8× (HR 68.840, 95% CI 8.250–574.500, p<0.001) and 19.9× (HR 19.990, 95% CI 
2.522–158.400, p=0.005), respectively (Table 3). This demonstrates an increase in accuracy of risk 
stratification when compared to the conventional R- or R+1-classifications. Other independent risk 
factors for LR, other than margin status included unplanned excision (unplanned excision HR 5.016, 
95% CI 2.451–10.270, p<0.001, versus planned excision HR, 1), and tumour size (≥ 10 cm HR 2.375, 
95% CI 1.165–4.631, p=0.017, versus < 5 cm HR 1; 5–9.9 cm HR 3.077, 95%CI 1.423–6.653, 
p=0.004, versus < 5 cm HR 1) (Table 3). 
 
The relationship between resection margin in millimetres and disease-specific mortality 
The 5-year cumulative incidence of disease-specific death was 31% (95% CI, 26–35%) with a 
median follow-up of 61 months (range, 1 to 203 months). According to univariate analysis, 
increasing tumour size, higher grade, and the presenc  of LR were poor prognostic factors. In 
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multivariate analysis using Fine–Gray subdistribution hazard model, tumour grade (grade-3 HR 
1.630, 95% CI 1.174–2.263, p=0.005, versus grade-2 HR 1), tumour size (≥ 10 cm HR 2.786, 95% 
CI 1.638–4.738, p<0.001, versus < 5 cm HR 1; 5–9.9 cm HR 2.065, 95% CI 1.238–3.445, p=0.005, 
versus < 5 cm), and presence of LR (presence HR 2.437, 95% CI 1.637–3.627, p<0.001, versus 
absence HR 1) were independent prognostic predictors for disease-specific survival, but the none of 
the margin classification showed significant association with survival outcomes (Figure 3 and 
Supplementary Figure 2).  
 
Discussion 
This study has confirmed the margin status, defined by conventional R- or R+1-classification, is an 
independent prognostic factor for LR, in agreement with previous publications [3, 26]. In a recent 
study of 2,217 patients with localised STS, Gundle et al. reported that these classifications were both
independent predictors for LR, with the 10-year LR rates for R0, R1, and R2 margins being 8%, 21% 
(or 12%), 44% by the R- (or R+1)-classification, resp ctively [3]. Our investigation reported 5-year 
LR rates with R0, R1, and R2 margins of 8%, 23% (16%), and 31% for R0, R1, and R2 by R- (or 
R+1)-classifications, respectively. However, the 9% risk of LR in patients with R0 resections 
identified in this study suggests these classificaton systems lack the detail to truly predict LR risk. 
Furthermore, these classifications were not sensitive enough to stratify the risk of LR with statistical 
significance in patients with negative margin. Using the novel classification system proposed in this 
study, the risk of LR significantly decreased if a clear margin was obtained but was similar to the risk
of LR with resection margins less than 5mm, at 10%. However, the LR risk markedly decreased to 
approximately 1–2% with margins over 5 mm, suggesting hat this metric measure of margins is a 
more accurate descriptor than the R- and R+1-classification. The risk of LR was clearly stratified by 
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the margin width of 5 mm in patients with negative margin.  
The effect of margin on local control has been well documented in the literature. Dickinson 
et al. stratified patients into five groups; contaminated, < 1 mm but clear, 1–4 mm, 5–9 mm, and 10–
19 mm. They observed the highest local control rates in patients with 1–4 mm, concluding that a 
margin greater than 1 mm was satisfactory [11]. Novais et al. classified margins into four groups; 
positive, < 2 mm but clear, 2–20 mm, and > 20 mm, and demonstrated that a margin ≤ 2mm was 
significantly associated with a higher risk for LR [13]. Liu et al. stratified patients into six groups; 0–
1 mm, 1–4 mm, 5–9 mm, 10–19 mm, 20–29 mm, and ≥ 30 mm. They described that margin ≥ 10 
mm was one of the independent prognostic factors for LR-free survival [29]. However, the study 
populations in these studies comprised a mixture of infiltrative and non-infiltrative sarcomas. In 
general, wider margins are necessary for local control in infiltrative STSs such as myxofibrosarcoma 
and undifferentiated pleomorphic sarcoma [15], which has a high LR rate as tumours typically 
spread extensively along fascial planes [30]. Indeed, cases with LR in these published series included 
substantial numbers of infiltrative subtypes, which may explain the discrepancy in the accepted 
metric margin among these studies. Our group recently reported the role of margin in millimetres in 
infiltrative STSs [31]; the LR risk was lowest if the resection margin was ≥ 10mm. Thus, the extent 
of margin width for optimising local control seems to be less in non-infiltrative STSs (> 5mm) than 
in infiltrative subtypes (≥ 10mm). We believe that our analysis, focusing on the non-infiltrative entity, 
would provide more precise information for surgical planning and postoperative surveillance. 
Ahmad et al. recently investigated the relationship of the width of surgical margin and 
radiotherapy for localized STS patients who underwent limb-sparing surgery, stratified by three 
groups; ≤ 1mm, 1–5 mm, and > 5mm [16]. Although they observed a significant difference in LR 
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rate between positive and negative margin, there was no difference in LR rates among groups with 
negative margins and concluded that the width of margin does not influence outcomes in STS treated 
with RT. However, there was a clear trend towards improved outcomes in patients with > 5 mm 
margins which failed to achieve statistical significance, attributed to the limited number of patients i  
that group (n=28) compared to those with ≤ 1mm (n=128) and 1–5 mm (n=79) margins. Our 
analyses, focusing on the non-infiltrative subtypes, identified clear stratification of LRFS between 
positive margin, 0.1–5.0 mm, and > 5.0 mm with stati ical significance in both patients either with 
or without adjuvant radiotherapy. These data indicate the crucial role of resection margins regardless 
of the use of adjuvant radiotherapy for these subtypes. 
There is no consensus regarding the efficacy of adjuv nt RT for patients with positive 
margins [1]. In this study, we observed no significant difference in the LR rates between patients 
with and without adjuvant RT when resection margins were positive (5-year cumulative LR 
incidence: 29% with RT versus 28% without RT; p = 0.617). Alkektiar et al. and Sadoski et al. 
reported that positive margins were associated with poor LR-free survival even with adjuvant RT [32, 
33]. In contrast, Kim et al. reported that positive or close margins had no negative effect on local 
failure when adjuvant RT was performed [34]. There is no consensus regarding the RT dose for local 
control in patients with positive margins. Delaney et al. described that a RT dose >64 Gy could 
provide better local control in STS patients with positive margins [35]. Conversely, Levy et al. 
analysed differences in LR rates between ≥55 Gy and <55 Gy in patients with positive margins 
(defining a surgical margin < 1 mm as a “positive” margin) and reported no significant difference 
(5-year LR rate; 23% with ≥55 Gy versus 11% with <55 Gy; p = 0.200) [36]. They also included 
specific analyses of patients with R1 margins (defined as microscopically positive margins), 
observing that patients with R1 margins who received higher RT doses had an increased LR rate 
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(5-year LR rate; 15% with ≥55 Gy versus 4% with <55 Gy; p < 0.001) [36]. Zagars et al. 
demonstrated that higher RT doses were not able to fully overcome the adverse effects of positive 
margins [37]. We observed no significant advantage of adjuvant RT in patients with positive margins, 
supporting previous evidence that achieving a negative margin remains critical, even in patients 
receiving adjuvant RT.  
The influence of surgical margins on survival is alo not clear. In a retrospective study with 
2,084 adult patients with localized STSs, Stojadinovic et al. stated that microscopically positive 
margins significantly decreased LR-free survival, metastasis-free survival, and disease-specific 
survival [20]. Similarly, Dickinson et al. reported that patients with contaminated margin had
significantly higher risk of mortality compared to hose with 20 mm or greater margins, although 
there was no significant difference for those with uncontaminated margins of up to 19 mm [11]. In 
contrast, Bonvalot et al. investigated 531 patients with extremity STSs and reported that neither 
margin status nor LR had an effect on overall survival while margins < 1 mm affected the risk of LR 
[38]. In this study, no statistically significant correlation between margin status and overall survival 
was seen. However, the development of LR was associated with poorer survival outcomes. Whilst 
we cannot directly attribute the margin status to the effect on overall survival, it can be inferred that 
where margin status effects LR, and LR effects overall survival, margin status has an indirect effect 
on overall survival. Further investigation with a larger cohort is clearly required to more accurately 
assess this risk.  
We acknowledge several limitations to this study. First, the quantitative margin width in 
millimetres was not available in approximately half the patients with negative margins in this study 
period. Thus, the proportion of positive margins in this cohort was higher than the actual data. 
Second, the data on the quality of surgical margin were not available in all patients. Therefore, we 
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cannot make meaningful conclusions about the nature of the margin material and the effect this may 
have on LR and overall survival. Previous investigations have suggested that some margin tissues 
such as fascia or periosteum function as barriers against tumour infiltration. Further analysis 
considering the margin quantitative width and the margin quality would provide better risk 
stratification in local control for STSs. Third, the detailed information from the record regarding 
positive margins was unavailable. Gundle et al. previously classified positive margins into three 
categories: inadvertent positive margin; planned close but with an ultimately positive microscopic 
margin along a critical structure; and positive margin after a tumour bed re-excision in patients 
treated initially with inadequate surgery elsewhere [3]. In their study, no significant differences were 
observed in the 10-year LR rates between positive margins on critical structures and R0 margins 
(11% versus 8%), however inadvertent positive margins (35%) and positive margin after a tumour 
bed re-excision (24%) both exhibited higher LR rates [3]. Further research into positive margins in 
the present study cohort may provide information cotributing to further categorization of the margin 
system for STSs. Fourth, radiotherapy details such as such as radiation field and dose were 
unavailable, as the delivery of radiotherapy was performed at outside institutions. This variation in 
dose and radiation field may explain the discrepancy we see in the effect of adjuvant radiotherapy on 
LR, particularly for patients with narrow or involved margins. Finally, the study population 
comprised various histological subtypes, though we att mpted to harmonise the cohort by excluding 
tumour types known to have an infiltrative growth pattern. We believe this offers a more accurate 
assessment of the effect of margin on LR when compared to other studies which included all 
histological variants, including infiltrative myxofibrosarcoma and undifferentiated pleomorphic 
sarcomas, subtypes known to have a high risk of LR [17].   
In summary, achieving a negative margin is essential to optimise local control regardless of 
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the use of adjuvant radiotherapy in patients with non-infiltrative subtypes of STS. Surgical margins 
greater than 5 mm minimise the risk of LR, regardless of adjuvant radiotherapy. This system more 
accurately predicted this risk of LR when compared to the conventional R- and R+1- classifications. 
The role of resection margin for survival prognosis remains unclear, requiring further investigation 
with a larger patient cohort. 
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Figure 1. Cumulative incidence of local recurrence stratified by margin classification; 
R-classification (A), R+1-classification (B), three-group classification by metric distance (positive; 
clear, ≤5 mm; clear, > 5 mm; C). 
 
Figure 2. Cumulative incidence of local recurrence stratified by three-group margin classification by 
metric distance (positive; clear, ≤5 mm; clear, > 5 mm) in patients with (A) and without (B) adjuvant 
radiotherapy. 
 
Figure 3. Cumulative incidence of disease-specific death stratified by three-group margin 
classification by metric distance (positive; clear, ≤5 mm; clear, > 5 mm). 
 
Table 1. Patient characteristics 
  




Age at diagnosis (median) 52 2–92 
Gender Male 300 60% 
 
Female 202 40% 
Site Lower extremity 339 68% 
 
Upper extremity 91 18% 
 
Trunk/neck 44 9% 
Depth Deep 361 72% 
 
Superficial 141 28% 
Diagnosis Synovial sarcoma 122 24% 
 
Myxoid liposarcoma 119 24% 
 
Leiomyosarcoma 88 18% 
 
MPNST 66 13% 
 
Dedifferentiated liposarcoma 16 3% 
 
Clear cell sarcoma 13 3% 
 
Pleomorphic liposarcoma 12 2% 
 
Extraskeletal myxoid chondrosarcoma 12 2% 
 
Alveolar soft part sarcoma 6 1% 
 
Others 48 9% 
Grade (FNCLCC) Grade 2 194 39% 
 
Grade 3 308 61% 
Tumour size ≤5cm 142 28% 
 
>5cm, ≤10cm 195 39% 
 
>10cm 165 33% 
UICC stage IIA 124 25% 
 
IIB 75 15% 
 
III 300 60% 
Unplanned excision Yes 75 15% 
 
No 427 85% 
Chemotherapy Yes 79 16% 
 
No 423 84% 
Radiotherapy Yes 375 75% 
  No 127 25% 
  
Table 2. Local recurrence according to the surgical margin width and the use of radiotherapy 
Margin width 
(mm) 







Yes Total Yes Total Yes Total 
0 26 95 27% 3 14 21% 23 58 28% 
0.1–1.0 27 236 11% 5 25 20% 22 211 10% 
1.1–2.0 6 49 12% 1 10 10% 5 39 13% 
2.1–5.0 4 37 11% 2 14 14% 2 23 9% 
5.1–20.0 1 25 4% 1 12 8% 0 13 0% 
>20.0 0 60 0% 0 55 0% 0 5 0% 
Total 64 502 13% 12 130 9% 52 372 14% 
 
  
Table 3. Multivariate analysis using Fine–Gray subdistribution hazard model for LR and disease-specific mortality 
Variable Detail 
LR Disease-specific death 
HR 95% CI p value HR 95% CI p value 





>5cm, ≤10cm 2.375 1.165–4.631 0.017 2.065 1.238–3.445 0.005 
 
>10cm 3.077 1.423–6.653 0.004 2.786 1.638–4.738 <0.001 





Deep 1.12 0.611–2.171 0.660 0.834 0.554–1.254 0.380 





Grade 3 1.601 0.931–2.753 0.089 1.630 1.174–2.263 0.004 





Yes 5.016 2.451–10.270 <0.001 1.057 0.645–1.732 0.830 





No 1.287 0.665–2.491 0.450 0.771 0.474–1.254 0.290 





No 0.769 0.375–1.578 0.470 1.232 0.773–1.963 0.380 
Resection margin >5mm 1   1   
 
>0mm, ≤5mm 19.990 2.522–158.400 0.005 1.013 0.599–1.712 0.960 
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